ACTIVE

CANCER STATE THERAPEUTICS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-690,5 k €-52,9 %over 1 year
Gross margin-105,3 k €+8,4 %over 1 year
Equity3,7 M €+771,2 %over 1 year

Identity

Source · BCE/KBO

CANCER STATE THERAPEUTICS is a Private limited company incorporated in 2022. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Charleroi.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0793.113.273
Incorporation
28/10/2022
Legal form
Private limited company
Registered office
Rue Auguste Piccard 48
6041 Charleroi · WallonieSee on map
Contributed capital
5 211 175,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 207
Signals
Solid equityLow riskGood liquidityHealthy social debts

Financials

Source · NBB, 4 filings

Trend over 3 financial years

202520242023
Income statement
Gross margin-105,3 k €-114,9 k €-186,6 k €
EBITDA-707,9 k €-447,4 k €-336,3 k €
Operating result-742,9 k €-458,3 k €-338 k €
Net result-690,5 k €-451,6 k €-330,5 k €
Balance sheet
Equity3,7 M €429,2 k €880,7 k €
Total assets4 M €600,1 k €1,3 M €
Cash171,9 k €365,4 k €760,4 k €
Debts222,2 k €139,7 k €467,2 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 4 ended

Active mandates

François Delvaux

Director · since 27 janvier 2025

Active
Pierre Chevalier

Director · since 27 janvier 2025

Active
Ahmed Fahim

Director

Active
Cédric Blanpain

Managing director

Active
Gaetan Waucquez

Director

Active
Jean-Claude Marian

Director

Active

Ended mandates

Cédric Blanpain

Managing director · since 25 mai 2023

Ended
Ahmed Fahim

Director · since 03 mai 2023

Ended
Gaetan Waucquez

Director · since 03 mai 2023

Ended
Jean-Claude Marian

Director · since 03 mai 2023

Ended

Other companies at this address

Rue Auguste Piccard 48 6041 Charleroi
CompanyCBE no.
European Infrared Technologies● Active
0643.646.468
Genflow Biosciences● Active
0753.904.685
HEARTKINETICS● Bankrupt
0728.461.387
NEUVASQ BIOTECHNOLOGIES● Active
0762.966.663
SYNABS● Active
0637.716.206
T-knife Therapeutics● Active
1037.005.620

Full financial information

Source · NBB
202520242023
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202428/10/2022
Closing of the financial year31/12/202531/12/202431/12/2023
Length of the financial year12 months12 months15 months
Filing date15/05/202630/05/202519/05/2025
General meeting04/05/202605/05/202506/05/2024
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202504/05/202615/05/2026FrenchPDF
Micro model31/12/202405/05/202530/05/2025FrenchPDF
Micro modelCorrection31/12/202306/05/202419/05/2025FrenchPDF
Micro model31/12/202306/05/202403/07/2024FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 4 ended

Active mandates

François Delvaux

Director · since 27 janvier 2025

Active
Pierre Chevalier

Director · since 27 janvier 2025

Active
Ahmed Fahim

Director

Active
Cédric Blanpain

Managing director

Active
Gaetan Waucquez

Director

Active
Jean-Claude Marian

Director

Active

Ended mandates

Cédric Blanpain

Managing director · since 25 mai 2023

Ended
Ahmed Fahim

Director · since 03 mai 2023

Ended
Gaetan Waucquez

Director · since 03 mai 2023

Ended
Jean-Claude Marian

Director · since 03 mai 2023

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares09/07/2026
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Registered office18/06/2025
    SIEGE SOCIAL
    PDF
  • Registered office25/04/2025
    SIEGE SOCIAL
    PDF
  • Mandates30/01/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DIVERS - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates10/06/2024
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates20/07/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares09/03/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DIVERS - CAPITAL, ACTIONS
    PDF
  • Other03/11/2022
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-690,5 k €↓
  2. 2024
    Annual accounts 2024-451,6 k €↓
  3. 2023
    Annual accounts 2023-330,5 k €
  4. 28/10/2022
    IncorporationPrivate limited company